These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2033417)

  • 1. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?
    Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E
    J Clin Oncol; 1991 Jun; 9(6):1037-44. PubMed ID: 2033417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: an unselected group of stage IV patients over 1 year of age.
    Philip T; Bernard JL; Zucker JM; Pinkerton R; Lutz P; Bordigoni P; Plouvier E; Robert A; Carton R; Philippe N
    J Clin Oncol; 1987 Feb; 5(2):266-71. PubMed ID: 3543245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.
    Garaventa A; Rondelli R; Lanino E; Dallorso S; Dini G; Bonetti F; Arrighini A; Santoro N; Rossetti F; Miniero R; Andolina M; Amici A; Indolfi P; Lo Curto M; Favre C; Paolucci P; Pession A; De Bernardi B
    Bone Marrow Transplant; 1996 Jul; 18(1):125-30. PubMed ID: 8832005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose chemoradiotherapy with bone marrow transplantation as a consolidation treatment of neuroblastoma. Results in 49 unselected patients with stage IV cancer and older than 1 year. Report of the LMCE neuroblastoma group].
    Kremens B; Philip T; Bernard JL; Zucker JM
    Klin Padiatr; 1987; 199(3):218-23. PubMed ID: 3306132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intensive chemotherapy and bone marrow grafting during the consolidation phase of stage IV neuroblastoma].
    Philip T; Zucker JM; Bernard JL; Bordigoni P; Souillet G; Robert A; Roche H; Philip I; Chauvin F; Favrot MC
    Bull Cancer; 1988; 75(1):113-7. PubMed ID: 3282573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases.
    Dini G; Lanino E; Garaventa A; Rogers D; Dallorso S; Viscoli C; Castagnola E; Manno G; Brisigotti M; Rosanda C
    J Clin Oncol; 1991 Jun; 9(6):962-9. PubMed ID: 2033431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
    Kushner BH; Gulati SC; Kwon JH; O'Reilly RJ; Exelby PR; Cheung NK
    Cancer; 1991 Jul; 68(2):242-7. PubMed ID: 1906368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
    Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK
    J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
    Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
    J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].
    Dini G; Garaventa A; Lanino E; Perin GP; Scarpati D; Viscoli C; Franchini E; Corvò R; Dallorso S; Cinollo G
    Pediatr Med Chir; 1987; 9(1):1-7. PubMed ID: 3306621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.
    Ladenstein R; Philip T; Lasset C; Hartmann O; Garaventa A; Pinkerton R; Michon J; Pritchard J; Klingebiel T; Kremens B; Pearson A; Coze C; Paolucci P; Frappaz D; Gadner H; Chauvin F
    J Clin Oncol; 1998 Mar; 16(3):953-65. PubMed ID: 9508178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
    McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
    J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
    Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete surgical resection combined with aggressive adjuvant chemotherapy and bone marrow transplantation prolongs survival in children with advanced neuroblastoma.
    Chamberlain RS; Quinones R; Dinndorf P; Movassaghi N; Goodstein M; Newman K
    Ann Surg Oncol; 1995 Mar; 2(2):93-100. PubMed ID: 7728576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II study.
    Pinkerton CR; Philip T; Biron P; Frapazz D; Phillipe N; Zucker JM; Bernard JL; Philip I; Kemshead J; Favrot M
    Med Pediatr Oncol; 1987; 15(5):236-40. PubMed ID: 3309605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
    Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
    Martino M; Postorino M; Gallo GA; Messina G; Neri S; Piro E; Gentile M; Moscato T; Monteleone R; Fedele R; Mazzone C; Console G; Penna G; Alati C; Vincelli ID; Irrera G; Musolino C; Ronco F; Molica S; Morabito F
    Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):148-54. PubMed ID: 24417912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.